Ming Guo, M.D., Ph.D., is P. Gene & Elaine Smith Chair in Alzheimer's Disease Research and Professor at UCLA Department of Neurology, Molecular and Medical Pharmacology. As a practicing Neurologist, she sees patients with memory disorders, neurodegenerative and neurogenetic disorders, referred from both domestic and international sources. As a researcher, her lab investigates molecular mechanisms of the two most common neurodegenerative disorders, Alzheimers and Parkinsons disease. Mutations in PINK1 and PARKIN lead to inherited forms of Parkinsons disease. Her lab is one of the first two labs worldwide to report the function of PINK1, and to discover that PINK1, a mitochondria-localized serine-threonine kinase, and PARKIN, an E3 ubiquitin ligase, act in a common genetic pathway to regulate mitochondrial integrity and mitochondrial quality control. Her work has wide-range implications for controlling processes in aging, and other aging-related diseases including other neurodegenerative disorders, heart disease and metabolic disorders.
Dr. Guo is an elected member of the American Neurological Association (ANA), and has received many awards. She is an Alfred P. Sloan Foundation fellow, a McKnight Neuroscience Foundation Brain Disorder Awardee, an Ellison Medical Foundation Senior Scholar in Aging, a Klingenstein-Simons Fellow in Neuroscience, and the Klingenstein-Simon Foundation Robert H. Ebert Clinical Scholar. Her work is also supported by the National Institute of Health (NIH) EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) award. In addition, she was selected to receive the ANA Derek Denny Brown Neurological Scholar Award that is given to one or two awardees each year, and the John Walsh Young Investigator Award, which is given to one Assistant or Associate professor every three years for their research creativity at UCLA.
Dr. Guo is actively involved in community service. She is Chair of the Board of Scientific Counselors at the National Institute of Neurological Disorders and Stroke (NIH/NINDS). She also serves as a member of a Blue Ribbon Panel for the NIH/NINDS, the ANA Scientific Program Advisory Committee, the Society of Neuroscience Program Committee, and the Scientific Advisory Committee of the A.P. Giannini Foundation in California.
A selected list of publications:
Zhang T, Mishra P, Hay BA, Chan D and Guo M
VCP inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants,
2017; in press:
Kandul, N.P., Zhang, T., Hay, B.A.*, and Guo, M* (equal contribution).
Selective removal of deletion-bearing mitochondrial DNA in heteroplastic Drosophila,
2016; in press:
Harteinstein, V.*, Cruz, L., Lovick, J.K., and Guo, M.* (co-correspondence)
Developmental analysis of the dopamine-containing neurons of the Drosophila brain,
Journal of Comparative Neurology,
Yun, J., Puri, R.*, Yang, H.*, Lizzio, M., Wu, C., Sheng, Z.H. and Guo, M.
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin,
Dauer WT, Guo M.
Multiplying messages LRRK beneath Parkinson disease,
Dodson, M.W., Leung, L.K., Lone, M. Lizzio, M.A. and Guo, M.
Novel alleles of the Drosophila LRRK2 homolog reveal a crucial role in endolysosomal functions and autophagy in vivo,
Disease Models and Mechanisms,
Gross GG, Lone GM, Leung LK, Hartenstein V, Guo M.
X11/Mint genes control polarized localization of axonal membrane proteins in vivo,
J. Neurosci. ,
8575-8586 (cover story).
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease,
Cold Spring Harb. Perspect. Med,
M.W. Dodson, T. Zhang, C. Jiang, S. Chen and M. Guo
Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning,
Human Molecular Genetics,
J.C. Rochet, B.A. Hay and M. Guo
Molecular Insights into Parkinson's Disease,
Progress in Molecular Biology and Translational Science,
What have we learned from Drosophila models of Parkinson?s disease,
Progress in Brain Research,
B.A. Hay, C.H. Chen, C. M. Ward, H. Huang. J. T.Su, and M. Guo
Engineering the genomes of wild insect populations: Challenges, and opportunities provided by synthetic Medea selfish genetic elements,
J. Insect Physiol. ,
Li, H. and
Protein Degradation in Parkinson Disease Revisited: It's Complex ,
J. Clinical Invest,
Chen, C., Huang, H., Ward, C., Su, J., Schaeffer, L., M. Guo and Hay, B.A.
A Synthetic Maternal-Effect Selfish Genetic Element Drives Population Replacement in Drosophila
Clark, I.E*., Dodson, M.W.*, Jiang, C.*, Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A. and Guo, M.
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Xu P, Guo M, Hay BA.
MicroRNAs and the regulation of cell death,
Guo, M., Hay, B.
Cell proliferation and apoptosis,
Curr Opin Cell Biol. ,